State AGs urge HHS to sidestep Gilead patents to boost remdesivir access
A bipartisan group of state attorneys general is urging the federal government to sidestep Gilead’s remdesivir patents to increase access to the drug.
A bipartisan group of state attorneys general is urging the federal government to sidestep Gilead’s remdesivir patents to increase access to the drug.
Download STAT’s e-book to explore the challenges and steps to improve care for an aging population.
A nonprofit group is doing deals in Brazil and India to make low-cost CAR-T cell therapies widely available.
“For some reason in rehabilitation research, we’ve kind of lost that ethos” of centering patients, says James Sulzer on a new episode of the “First…
How is it that so much bird flu virus is getting off of affected dairy farms and into the national milk supply?
RFK Jr. said doctors had found a dead worm in his brain.
At least 224 diabetes patients have been harmed by a software error causing their insulin pumps to spontaneously shut down, the FDA said Wednesday.
Despite the negative finding, researchers said there is still promise in the strategy of amplifying and infusing the immune cells of newly diagnosed type 1…
Two congenitally deaf children can hear after being treated with a gene therapy, according to new data from an ongoing clinical trial.
Google on Wednesday unveiled an AI tool capable of predicting the structure and interaction of a vast universe of biomolecules.
STAT Breakthrough Summit West is one-day event designed to break down silos across health and medicine by bringing together leaders, entrepreneurs, policymakers, patient advocates —…